1.Official Positions of the International Society for Clinical Densitometry.
Journal of Korean Society of Endocrinology 2005;20(1):1-7
No abstract available.
Densitometry*
2.Quality Control of DXA System and Precision Test of Radio-technologists.
Journal of Bone Metabolism 2014;21(1):2-7
The image quality management of bone mineral density (BMD) is the responsibility and duty of radio-technologists who carry out examinations. However, inaccurate conclusions due to the lack of understanding and ignorance regarding the methodology of image quality management can be a fatal error to patients. The accuracy and precision of BMD measurement must be maintained at the highest level so that actual biological changes can be detected with even slight changes in BMD. Accuracy and precision should be continuously preserved for image quality of machines. Those factors will contribute to ensure the reliability of BMD examination. The enforcement of proper quality control of radiologists performing BMD inspections which brings about the durability extensions of equipment and accurate results of calculations will help the assurance of reliable inspections.
Absorptiometry, Photon
;
Bone Density
;
Densitometry
;
Humans
;
Quality Control*
3.Result of Proficiency Test and Comparison of Accuracy Using a European Spine Phantom among the Three Bone Densitometries.
Ae Ja PARK ; Jee Hye CHOI ; Hyun KANG ; Ki Jeong PARK ; Ha Young KIM ; Seo Hwa KIM ; Deog Yoon KIM ; Seung Hwan PARK ; Yong Chan HA
Journal of Bone Metabolism 2015;22(2):45-49
BACKGROUND: Although dual energy X-ray absorptiometry (DXA) is known to standard equipment for bone mineral density (BMD) measurements. Different results of BMD measurement using a number of different types of devices are difficult to use clinical practice. The purpose of this study was to evaluate discrepancy and standardizations of DXA devices from three manufactures using a European Spine Phantom (ESP). METHODS: We calculated the accuracy and precision of 36 DXA devices from three manufacturers (10 Hologic, 16 Lunar, and 10 Osteosys) using a ESP (semi-anthropomorphic). The ESP was measured 5 times on each equipment without repositioning. Accuracy was assessed by comparing BMD (g/cm2) values measured on each device with the actual value of the phantom. Precision was assessed by the coefficient of variation (CVsd). RESULTS: Lunar devices were, on average, 22%, 8.3%, and 5% overestimation for low (L1) BMD values, medium (L2), and high (L3) BMD values. Hologic devices were, on average, 6% overestimation for L1 BMD, and 5% and 6.2% underestimation for L2 and L3 BMD values. Osteosys devices was, on average, 12.7% (0.063 g/cm2), 6.3% (0.062 g/cm2), and 5% (0.075 g/cm2) underestimation for L1, L2, and L3, respectively. The mean CVsd for L1-L3 BMD were 0.01%, 0.78%, and 2.46% for Lunar, Hologic, and Osteosys devices respectively. CONCLUSIONS: The BMD comparison in this study demonstrates that BMD result of three different devices are significant different between three devices. Differences of BMD between three devices are necessary to BMD standardization.
Absorptiometry, Photon
;
Bone Density
;
Densitometry*
;
Lumbar Vertebrae
;
Spine*
4.Utility of radius bone densitometry for the treatment of osteoporosis with once-weekly teriparatide therapy
Harumi NAKAYAMA ; Hiroyuki TOHO ; Teruki SONE
Osteoporosis and Sarcopenia 2018;4(1):29-32
OBJECTIVES: As clinics that treat patients with osteoporosis do not usually have central dual-energy X-ray absorptiometry (DXA), bone density is often measured with radial DXA. However, no long-term evidence exists for radius bone density outcomes following treatment with once-weekly teriparatide in actual medical treatment. METHODS: We evaluated changes in bone density at 6-, 12-, and 18-month intervals using radial DXA in patients treated with once-weekly teriparatide for more than 6 months. RESULTS: A significant increase in bone mineral density (BMD) was observed at the 1/3 and 1/10 radius sites 12 months after the initiation of once-weekly teriparatide. We also observed that the rate of change in BMD was greater at the distal 1/10 radius than at the 1/3 radius. CONCLUSIONS: Considering these points, the effect of once-weekly teriparatide therapy can be observed at the radius. In clinics that do not have central DXA, but instead have radial DXA, these findings can help to evaluate the effect of once-weekly teriparatide treatment on osteoporosis.
Absorptiometry, Photon
;
Bone Density
;
Densitometry
;
Humans
;
Osteoporosis
;
Radius
;
Teriparatide
5.Clinical Application of Bone Mineral Density Measurement.
Korean Journal of Nuclear Medicine 2004;38(4):275-281
Compared with the earlier technique of dual photon absorptiometry (DPA) using 153Gd radionuclide source, dual energy X-ray absorptiometry (DXA) has advantages of higher precision, accuracy and shorter scanning time. Despite the change from DPA to DPX, the nuclear medicine physicians has remained one of major suplier of this service due to long-standing use of DPA. Among many kinds of bone densitometries, DXA is the "gold standard" for the noninvasive diagnosis of osteoporosis. Especially there is no role for peripheral devices in the monitoring of patients on therapy. But, there are some areas of controversy related to the application of DXA, such as proper site of measurement, accurate interpretation, appropriate use of T-score, and the reference population young database. And the accuracy, precision, and quality control issues relating to bone density measurement are important subjects. To address these issues, the International Society for Clinical Densitometry (ISCD) has convened two Position Development Conferences and addressed official positions. This review deals the key elements of ISCD position paper and other important issues on the management of bone densitometry.
Absorptiometry, Photon
;
Bone Density*
;
Congresses as Topic
;
Densitometry
;
Diagnosis
;
Humans
;
Nuclear Medicine
;
Osteoporosis
;
Quality Control
6.Dual-Energy X-Ray Absorptiometry: Beyond Bone Mineral Density Determination.
Endocrinology and Metabolism 2016;31(1):25-30
Significant improvements in dual-energy X-ray absorptiometry (DXA) concerning quality, image resolution and image acquisition time have allowed the development of various functions. DXA can evaluate bone quality by indirect analysis of micro- and macro-architecture of the bone, which and improve the prediction of fracture risk. DXA can also detect existing fractures, such as vertebral fractures or atypical femur fractures, without additional radiologic imaging and radiation exposure. Moreover, it can assess the metabolic status by the measurement of body composition parameters like muscle mass and visceral fat. Although more studies are required to validate and clinically use these parameters, it is clear that DXA is not just for bone mineral densitometry.
Absorptiometry, Photon*
;
Body Composition
;
Bone Density*
;
Densitometry
;
Femur
;
Intra-Abdominal Fat
;
Sarcopenia
7.Standardization for Dual Energy X-ray Absorptiometry.
Jin A CHO ; Sang Woo KIM ; Auk KIM ; Ja Ran KU ; Yong Tae KIM ; Chang Hoon YIM ; Ki Oak HAN ; Ho Yeon CHUNG ; In Kwon HAN ; Hun Ki MIN
Korean Journal of Medicine 1997;52(4):445-449
OBJECTIVES: Bone densitometry is a current method for evaluating skeletal status, assessing osteoporosis, and determining fracture risk. DEXA has rapidly become a dominent method for evaluating skeletal status. But the comparison of patient data among different DEXA scanners is complicated because the instruments show differences in scanner design, bone mineral calibration, and analysis algorithms. The purpose of this study is making standardization of DEXA and comparability among different DEXA system. METHODS: Posteroanterior lumbar spine (L2-IA) measurements of healthy 83 racially homogenous Korean women, age 38-66 years (mean +/- 516, range of BMD 0.624-1.574g/cm) were obtained on a Lunar DPX-L, a Hologic QDR-2000, and a Norland XR-36. All sujects had no spinal deformities, ostophytes, fracture and scoliosis on thoracolumbar spinal X-ray. We performed the measurement of BMD in each subjects with different three scanners at the same time. RESULTS: The results of cross-calibration spinal BMD (L2-4, g/cm2) in patient study (r2=0.972-0.974); Lunar DPX-L=(1.149 X Hologic)+0.008=(1.022 X Norland)+0.137, Hologic QDR-2000=(0.847 X Lunar)+0.019= (0.876 X Norland)+0.124, and Norland XR-36=(0.954 X Lunar)-0.107=1.110 X Hologic)-0.113. The average absolute difference in patients` spinal BMD values (L2-L4) between Lunar and Hologic was 0.146g/cm2 (14%); it was 0.156g/cm2 (15%) between Lunar and Norland and 0.010g/cm2 (1%) between Hologic and Norland. CONCLUSIONS: The formula of this cross-calibration shows good correlation. We conclude that it is possible to compare the different spinal BMD values obtained on the different DEXA scanners.
Absorptiometry, Photon*
;
Bone Density
;
Calibration
;
Congenital Abnormalities
;
Densitometry
;
Female
;
Humans
;
Osteoporosis
;
Scoliosis
;
Spine
8.Diagnostic Value of the Bone Mineral Densitometry in the Metastatic Prostatic Cancer.
Kwang Sung PARK ; Soon Man PARK ; Hee Seung BUM ; Yang Il PARK
Korean Journal of Urology 1995;36(1):48-52
The bone scan in patients with prostate cancer remains to be the most sensitive method to assess the bone metastasis. But it is nonspecific and shows similar finding in either benign or malignant disease. Bone mineral densitometry allows for the quantification of total body bone mass. So we evaluated the efficacy of the measurement of the bone mineral density with dual-energy X-ray absorptiometry in patients with prostate cancer who had showed hot spot on the bone scan. Of the 15 patients 7 cases( 47% ) showed increased bone mineral density. To evaluate the efficacy of bone mineral densitometry, we analyze the 11 patients whose bone scan show hot spot on lumbar spine. Among them 2 cases( 18%) show osteoblastic finding on the bone x-ray, but 5 cases(45%) show increased density and 2 cases show decreased density on the bone mineral densitometry. These results show that the bone mineral densitometry is more valuable than bone x-ray in the detection of abnormal bone density. Therefore we suggest that bone mineral densitometry can be used as a helpful method of bone scan to detect the metastatic bone lesion in the advanced prostatic cancer.
Absorptiometry, Photon
;
Bone Density
;
Densitometry*
;
Humans
;
Neoplasm Metastasis
;
Osteoblasts
;
Prostatic Neoplasms*
;
Spine
9.Diagnosis of Osteoporosis.
Jae Gyoon KIM ; Young Wan MOON
Journal of the Korean Hip Society 2011;23(2):108-115
Osteoporosis is defined as a skeletal disorder characterized by compromised bone strength, predisposing an individual to increased fracture risk. Many factors can lead to the development of osteoporosis. It is usually asymptomatic unless osteoporotic fracture and secondary changes of bone structure occur. Early radiographs show normal findings; however, osteopenic appearance, fracture, cortical bone thinning, and roughening of bone trabeculae can be found according to severity of osteoporosis. These symptoms are most frequently found in the spine and proximal femur. Bone mineral density (BMD) is the standard method used to diagnose osteoporosis, and dual energy X-ray absorptiometry (DXA), one of the measurement tools for BMD, is particularly regarded as the appropriate tool applicable to WHO criteria, which defines osteoporosis as a T-score of less than 2.5 SDs below the mean of young adult women. Peripheral densitometry is less useful in predicting the risk of fractures of the spine and proximal femur, and it is not enough to diagnose and treat osteoporosis. Biochemical bone markers have demonstrated utility in clinical research and trials; however, they cannot replace BMD as a diagnostic tool. WHO recently developed FRAX, a novel method we can use to more conveniently evaluate osteoporotic fracture risk.
Absorptiometry, Photon
;
Bone Density
;
Densitometry
;
Female
;
Femur
;
Humans
;
Osteoporosis
;
Osteoporotic Fractures
;
Spine
;
Young Adult
10.A Difference of Bone Fracture Rate and Frequency to Have Determined in Diagnosis Standards
Tae Hee KIM ; Hae Hyeog LEE ; Soo Ho CHUNG
Journal of Korean Society of Osteoporosis 2010;8(3):266-270
OBJECTIVES: We evaluated the frequency of osteoporosis diagnosed in Bucheon postmenopausal women who attended our hospital using the World Health Organization (WHO) diagnostic criteria and the 2007 International Society for Clinical Densitometry (ISCD) official positions. And we evaluated a difference of bone fracture rate to have determined in diagnosis standards. MATERIAL & METHODS: From the database maintained in our department, we evaluated approximately 250 postmenopausal women, 45~69 years of age (mean, 56.9 years), between January 2005 and December 2007. We divided the women into 5 groups by age, and each group included 50 postmenopausal women. Bone mineral density (BMD) was measured using dual energy X-ray absorptiometry (DXA). RESULTS: When the WHO threshold for postmenopausal women was applied, the frequency of osteoporosis diagnosed was 22.8% at the lumbar spine, 30.4% at the femoral neck, and 38% in at least one of the evaluated sites. When the ISCD criteria were applied, the frequency of osteoporosis diagnosed was 14%, 2.8%, and 14.8%, respectively. The fracture rate of osteoporosis diagnosed using ISCD criteria and WHO thresholds were 4 patients (1.6%, P-value=0.021), 9 patients (3.6%, P-value=0.057) each. CONCLUSION: The frequency of osteoporosis diagnosed in postmenopausal women using the WHO criteria is much lower than the 2007 ISCD official positions. The WHO criteria are more liberal than the ISCD official positions. We anticipate new criteria that will unify these two methods of diagnosis.
Absorptiometry, Photon
;
Bone Density
;
Densitometry
;
Female
;
Femur Neck
;
Fractures, Bone
;
Humans
;
Osteoporosis
;
Spine
;
World Health Organization